Premium
Complete response is reversible upon vismodegib withdrawal and re‐inducible upon vismodegib rechallenge in a patient with locally advanced basal cell carcinoma
Author(s) -
Dessinioti C.,
Plaka M.,
Dimitrakopoulou A.,
Stratigos A.J.
Publication year - 2019
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.15428
Subject(s) - vismodegib , medicine , basal cell carcinoma , dermatology , basal cell